Current role
Biotechnology · Healthcare
Chief Accounting Officer
2022-07-31–present
Gregory Weinhoff
Chief Accounting Officer
Centessa Pharmaceuticals plc (CNTA)Equibles does not estimate personal net worth.
Get an email with a short summary when Centessa Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.
Get CNTA alertsAbout Gregory Weinhoff
Gregory Weinhoff is recorded as Chief Accounting Officer at Centessa Pharmaceuticals plc (CNTA) since July 31, 2022. Centessa Pharmaceuticals plc reported in an 8-K filed June 10, 2024 that Gregory Weinhoff was appointed Chief Business Officer, effective June 10, 2024. Centessa Pharmaceuticals plc reported in an 8-K filed July 8, 2022 that Gregory Weinhoff was appointed principal accounting officer, effective July 31, 2022. The proxy statement of Centessa Pharmaceuticals plc reports total compensation of $3,309,069 for Gregory Weinhoff in fiscal 2022, including a base salary of $465,800. Disclosed compensation is on record for 3 fiscal years. Centessa Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Centessa Pharmaceuticals plc includes Mario Alberto Accardi (CEO and Board Member), Francesco De Rubertis (Chairman), John Crowley (CFO) and 7 others.
“On June 10, 2024, the Company also announced that the Board has appointed Dr. Gregory Weinhoff as the Company's Chief Business Officer, on June 5, 2024, effective on the Start Date.”
“Effective as of July 31, 2022, Gregory Weinhoff, M.D., M.B.A., the Company’s Chief Financial Officer, will assume the duties and responsibilities of the Company’s principal accounting officer, in addition to the Company’s principal financial officer.”
Affiliation history
-
Current
2022-07-31–present
-
Centessa Pharmaceuticals plc (CNTA)
Proxy statement
CurrentStart not stated–present
Last confirmed April 29, 2026
-
Start not stated–2024-05-09
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Centessa Pharmaceuticals plc
- Mario Alberto Accardi CEO, Board Member
- Francesco De Rubertis Chairman
- John Crowley CFO
- Thomas Templeman CTO
- Iqbal Hussain General Counsel
- Gregory Weinhoff, M.D., M.B.A. Chief Accounting Officer
- Raphael Deferiere Chief Accounting Officer
- Raphael Deferiere, CPA Chief Accounting Officer
- Christopher Stokes Board Member
- Kristina Mignon Wright Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Centessa Pharmaceuticals plc (CNTA) | M.D., M.B.A Chief Financial Officer | $465,800 | $3,309,069 |
| 2021 | Centessa Pharmaceuticals plc (CNTA) | M.D., M.B.A Chief Financial Officer | $375,000 | $4,043,608 |
| 2020 | Centessa Pharmaceuticals plc (CNTA) | M.D., M.B.A Chief Financial Officer | — | — |